Invention Grant
- Patent Title: Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules
-
Application No.: US16977643Application Date: 2019-02-28
-
Publication No.: US11623927B2Publication Date: 2023-04-11
- Inventor: Kurt R. Brunden , Virginia M. Y. Lee , John Q. Trojanowski , Carlo Ballatore , Killian Oukoloff , Amos B. Smith, III
- Applicant: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA , THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Applicant Address: US PA Philadelphia; US CA Oakland
- Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US PA Philadelphia; US CA Oakland
- Agency: BakerHostetler
- International Application: PCT/US2019/020014 WO 20190228
- International Announcement: WO2019/169111 WO 20190906
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D487/04 ; C07D471/04 ; A61P25/28 ; C07D519/00
![Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules](/abs-image/US/2023/04/11/US11623927B2/abs.jpg.150x150.jpg)
Abstract:
The present disclosure provides compounds of formula (I) or (II) or a pharmaceutically acceptable salt or stereoisomer thereof, wherein Rx-R8 are defined herein. Also provided are compositions comprising a compound described herein and a pharmaceutically effective excipient, methods of stabilizing microtubules in a patient comprising administering to the patient a microtubule-stabilizing amount of a compound described herein, methods of treating cancer in a patient comprising administering to the patient a therapeutically effective amount of a compound described herein, and methods of treating a neurodegenerative disease in a patient comprising administering to the patient a therapeutically effective amount of a compound described herein.
Information query
IPC分类: